arsenic trioxide has been researched along with Carcinogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, B; Lu, M; Meng, X; Miao, Z; Qiao, X; Wu, L; Xue, D; Zhang, W | 1 |
| Chang, Y; Jiang, M; Zhou, Q; Zhou, R; Zhu, C | 1 |
2 other study(ies) available for arsenic trioxide and Carcinogenesis
| Article | Year |
|---|---|
Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic.
Topics: Amino Acid Motifs; Arsenic Trioxide; Arsenicals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Carcinogenesis; Cell Line; Cell Transformation, Neoplastic; Computational Biology; DNA Methylation; Gene Expression Regulation, Neoplastic; Hepatocytes; Humans; Liver; Liver Neoplasms; Oligonucleotide Array Sequence Analysis; Oxides; Promoter Regions, Genetic; RNA, Messenger; Signal Transduction; Transcription Factors; Transcriptional Activation; Wnt Proteins | 2015 |
microRNA-539 suppresses tumor growth and tumorigenesis and overcomes arsenic trioxide resistance in hepatocellular carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Hep G2 Cells; Humans; Liver; Liver Neoplasms; Male; Mice, Nude; MicroRNAs; Oxides | 2016 |